• Varilrix™/varilrix™ vaccine for prevention of varicella live attenuated

  Form: lyophilisate for solution for injection

  Active substance	Dosage
  live attenuated varicella virus Oka strain	not less than 103.3 IU

  ATC code: J07BK01

  Manufacturer: GlaxoSmithKline Biologicals S.A. (Batch release of finished product, release of solvent batches in ampoules and syringes; labeling and packaging of solvent in ampoules, quality control of solvent in ampoules, labeling and packaging of solvent in syringes, quality control of solvent in syringes, vaccine quality control, labeling and packaging of finished product) / Catalent Belgium (Manufacturing of solvent in syringes, quality control of solvent in syringes)

• Varivax vaccine for prevention of varicella live attenuated

  Form: powder and solvent for injection suspension

  Active substance	Dosage
  live attenuated varicella virus Oka/Merck strain	not less than 1350 IU

  ATC code: J07BK01

  Manufacturer: Merck Sharp & Dohme LLC, USA (Manufacturing, primary packaging and analytical testing of vaccine)